TUMOR DE TESTÍCULO
REFERÊNCIAS 1.
2.
3.
4.
5.
6.
7.
8.
Mannuel HD, Mitikiri N, Khan M, Hussain A: Testicular germ cell tumors: biology and clinical update. Curr Opin Oncol. 2012; 24(3):266-71. Dieckmann KP, Pichlmeier U: Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004; 22(1):2-14. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, et al.: Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004; 363(9417):1264-9. Sultan C, Paris F, Terouanne B, Balaguer P, Georget V, Poujol N, et al.: Disorders linked to insufficient androgen action in male children. Hum Reprod Update. 2001; 7(3):314-22. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE: Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol. 2005; 16(6):863-8. Weissbach L, Bussar-Maatz R, Löhrs U, Schubert GE, Mann K, Hartmann M, et al.: Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol. 1999; 36(6):601-8. von Eyben FE, Madsen EL, Blaabjerg O, Petersen PH, Jacobsen GK, Specht L, et al.: Serum lactate dehydrogenase isoenzyme 1 in patients with seminoma stage I followed with surveillance. Acta Oncol. 2002; 41(1):77-83. Hubert J, Descotes JL, Martin B: Urology imaging: imaging of germ cell tumors of the testis. Prog Urol. 2003; 13(5):969-84.
144